◀ Back to VCAM1

IL2 — VCAM1

Text-mined interactions from Literome

Shah et al., Cell Immunol 2003 (Ion Channel Gating) : MgTX can also inhibit IL-2 production and proliferation of T cells upon stimulation with anti-CD3 and VCAM-1
Banning et al., Free Radic Biol Med 2004 : Inhibition of basal and interleukin-1 induced VCAM-1 expression by phospholipid hydroperoxide glutathione peroxidase and 15-lipoxygenase in rabbit aortic smooth muscle cells
Schoen et al., Nutrition 2009 (Inflammation) : Furthermore, activation of natural killer cell cytotoxicity in response to interleukin-2 stimulation ( P < 0.05 ), a reduction of total lipid peroxidation, and a reduction of soluble vascular cell adhesion molecule-1 ( P < 0.01 ) and soluble intercellular adhesion molecule-1 ( P < 0.05 ) as inflammatory blood markers were found in the Regulat but not in the placebo group
Gerber et al., Immunology 2013 (Melanoma, Experimental) : We found that the local production of IL-2 enhances the number of interferon-? expressing CD8 T and natural killer cells in the tumour, as well as inducing expression of vascular cell adhesion molecule 1 on tumour vessels
Deisher et al., Life Sci 1993 (Second Messenger Systems) : Surface protein expression of vascular cell adhesion molecule-1 , endothelial leukocyte adhesion molecule-1, or intercellular adhesion molecule-1, which is induced by tumor necrosis factor, interleukin-1 , and lipopolysaccharide, was not induced by pentoxyfilline, a phosphodiesterase inhibitor, nor by dibutyryl cyclic adenosine monophosphate
Miller et al., J Leukoc Biol 1998 : Utilizing neutralizing antibodies, we show that CD40L mediated tissue factor and thrombomodulin modulation, as well as E-selectin and VCAM-1 upregulation, is independent of tumor necrosis factor alpha, interleukin-1alpha , or interleukin-1beta production